Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -1.92% | -3.77% | -68.52% |
May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 14.05M |
---|---|---|---|---|---|
Net income 2022 | -42M | Net income 2023 | -48M | EV / Sales 2022 | - |
Net cash position 2022 | 51.14M | Net cash position 2023 | 14.58M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.5
x | P/E ratio 2023 |
-0.26
x | Employees | 22 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.89% |
1 day | -1.92% | ||
1 week | -7.27% | ||
Current month | -0.01% | ||
1 month | -19.05% | ||
3 months | -55.46% | ||
6 months | -67.62% | ||
Current year | -68.52% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 1.02 | -1.92% | 10,099 |
24-07-02 | 1.04 | -2.80% | 4,745 |
24-07-01 | 1.07 | +4.89% | 13,295 |
24-06-28 | 1.02 | -7.26% | 21,430 |
24-06-27 | 1.1 | +3.77% | 8,019 |
Delayed Quote Nasdaq, July 03, 2024 at 01:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-68.52% | 5.69M | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- HEPA Stock